Aim To analyse the resolution of chest X-ray findings in relation to laboratory parameters in patients infected with acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a two- month followup. Analysis of chest X-ray findings in the first few months after the disease is the main goal of our work. Methods Out of the total of 343 patients chest X-ray findings were followed in 269 patients. Patients were divided into groups according to the severity of findings. D-dimer, inflammatory markers, blood cell count, neutrophil lymphocyte ratio (NLR) were analysed. Chest X-ray was analysed during the hospitalization on the day of admission, on the third, the seventh and the fourteenth day (scoring method was used). After discharge chest X-ray was performed in a two-week follow-up, then after one and two months, and after three months if necessary. Results Incomplete chest X-ray resolution was identified in 24 (39.34%) patients with severe, 27 (22.31 %) patients with moderate and in three (3.91%) patients with mild findings. Statistical significance was established in overall score by comparison between all groups (p<0.001), and in the moderate compared to the mild group (p=0.0051). The difference of NLR in the severe compared to the moderate group was observed (p=0.0021) and in the severe group compared to the mild group (p=0.00013). Conclusion Chest X-ray findings persisted mostly in the severe group followed by the moderate and mild ones. Long-term followup is necessary for the appropriate treatment and prevention of fibrosis, and reduction of symptoms.
Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology 2020:115–7.
2
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. Lancet 2020:497–506.
3
Ojo A, Balogun S, Williams O, Ojo O. Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies. Pulm Med 2020:6175964.
4
Strieter R, Mehrad B. New mechanisms of pulmonary fibrosis. Chest 2009:1364–70.
5
Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009:611–22.
6
Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol 2020:4381–9.
7
Schiaffino S, Tritella S, Cozzi A, Carriero S, Blandi L, Ferraris L, et al. Diagnostic performance of chest X-ray for COVID-19 pneumonia during the SARS-CoV-2 pandemic in Lombardy. Italy J Thorac Imaging 2020:105–6.
8
Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology 2020:715–21.
9
Huang L, Han R, Ai T, Yu P, Kang H, Tao Q, et al. Serial quantitative chest CT assessment of CO-VID-19: Deep-Learning approach. Radiol Cardiothorac Imaging 2020.
10
Venkatesan P. NICE guideline on long COVID. Lancet. Respir Med 2021:129.
11
Taylor E, Haven K, Reed P, Bissielo A, Harvey D, Mcarthur C, et al. Grant CC; SHIVERS Investigation Team. A chest radiograph scoring system in patients with severe acute respiratory infection: a validation study. BMC Med Imaging 2015:61.
12
Wong H, Lam H, Fong A, Leung S, Chin T, Lo C, et al. Frequency and distribution of chest radiographic findings in patients positive for COVID-19. Radiology 2020:72–8.
13
Kurupatham L, Chen M, Chan M, Vasoo S, Wang L, Tan B, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020:1488–94.
14
Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz E, et al. COVID-19: Specific and non-specific clinical manifestations and symptoms: The Current State of Knowledge. J Clin Med 2020:1753.
15
Bramson R, Griscom N, Cleveland R. Interpretation of chest radiographs in infants with cough and fever. Radiology 2005:22–9.
16
Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA 2020:603–5.
17
Zeng Y, Fu J, Yu X, Huang Z, Yin X, Geng D, et al. Should computed tomography (CT) be used as a screening or follow-up tool for asymptomatic patients with SARS-CoV-2 infection? Quant Imaging Med Surg 2020:1150–2.
18
Kim H, Capaccione K, Li G, Luk L, Widemon R, Rahman O, et al. The role of initial chest X-ray in triaging patients with suspected COVID-19 during the pandemic. Emerg Radiol 2020:617–62.
19
Borghesi A, Zigliani A, Masciullo R, Golemi S, Maculotti P, Farina D, et al. Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients. Radiol Med 2020:461–4.
20
Wallace W, Fitch P, Simpson J, Howie S. Inflammation associated remodelling and fibrosis in the lung: a process and an end point. Int J Exp Pathol 2007:103–10.
21
Strieter R. Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel. Chest 2005:526S – 532.
22
Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19 -an observational prospective multi-center trial. Eur Respir J 2020.
23
Cool C, Groshong S, Rai P, Henson P, Scott S, Brown K. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 2006:654–8.
24
Venkataraman T, Frieman M. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Res 2017:142–50.
25
Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J 2020:2001–17.
26
Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020:120–8.
27
Lechien J, Chiesa-Estomba C, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. COVID-19 Task Force of YO-IFOS. Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med 2020:335–44.
28
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020:2268–70.
29
Batlle D, Soler M, Sparks M, Hiremath S, South A, Welling P, et al. Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol 2020:1380–3.
30
Cummings M, Baldwin M, Abrams D, Jacobson S, Meyer B, Balough E, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020:1763–70.
31
Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020:1421–4.
32
Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020:55–8.
33
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Throm Haemost 2020:844–7.
34
Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt G, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003:1986–94.
35
Martines R, Ritter J, Matkovic E, Gary J, Bollweg B, Bullock H, et al. CO-VID-19 Pathology working group. Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States. Emerg Infect Dis 2020:2005–15.
36
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan. Lancet Respir Med 2020:475–81.
37
Tong J, Wong A, Zhu D, Fastenberg J, Tham T. The Prevalence of olfactory and gustatory dysfunction in COVID-19 patients: A systematic review and meta-analysis. Otolaryngol Head Neck Surg 2020:3–11.
38
Zhu N, Zhang D, Li W, Yang X, Song B, Zhao J, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med 2020.
39
Yufei Y, Mingli L, Xuejiao L, Xuemei D, Yiming J, Qin Q, et al. Utility of the neutrophil-tolymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19). Scand J Clin Lab Invest 2020:536–40.
40
Pimentel G, Vega D, Laviano C, A. High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients. Clin Nutr ESPEN 2020:101–2.
41
Li X, Liu C, Mao Z, Minglu X, Li W, Shuang Q, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care 2020:647.
42
Maroldi R, Rondi P, Agazzi G, Ravanelli M, Borghesi A, Farina D. Which role for chest x-ray score in predicting the outcome in COVID-19 pneumonia? Eur Radiol 2021:4016–22.
43
Rubin G, Ryerson C, Haramati L, Sverzellati N, Kanne J, Raoof S, et al. The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society. Chest 2020:106–16.
44
Monaco C, Zaottini F, Schiaffino S, Villa A, Pepa D, Carbonaro G, et al. Chest x-ray severity score in COVID-19 patients on emergency department admission: a two-centre study. Eur Radiol Exp 2020:68.
45
Chang Y, Yu C, Chang S, Galvin J, Liu H, Hsiao C, et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT. Radiology 2005:1067–75.
46
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020:1607–8.
47
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo F, Chong M, et al. Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State. JAMA 2020:1612–4.
48
Moore J, June C. Cytokine release syndrome in severe COVID-19. Science 2020:473–4.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
